Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • Kolamite
    Junior Member
    • Nov 2012
    • 7

    #1

    Tophat-fusion interpretation questions

    I'm new to RNA-sequencing in general and Tophat in particular, and I've got a few embarrassingly basic questions about the output that I was hoping someone could me help with.

    In the results file, I have a reported fusion event that looks like:

    Gene A | Chr Q | coordinate | Gene B | Chr R | coordinate | 3 1 4 | <--- <---

    Gene A is on the sense strand and has an overlapping antisense pseudogene. Gene B is on the antisense strand.

    Searching for the flanking sequences manually in IGV, I find that they're both from the antisense strand of their respective genes. Taking the Tophat output reads literally, it looks like the product is:

    Gene B-AS breakpoint Gene A-AS
    <----- XXX <-----

    My questions are:

    -Are the reads shown in Tophat meant as the actual product, or is it just a representation of the fused region?

    -How does Tophat determine the strands of the partners? In IGV, it appears that the few breakpoint-overlapping strands align in a near-even mix to the + and - strands for both chromosomes.

    -Why does Tophat report Gene A-AS as Gene A, and not the AS pseudogene? It gleefully reported some 300 other pseudogenes to me.

    The reason I'm asking these things is that if the fusion is real, Gene A-AS would not be coding even if the Gene B-AS part is. I'm wondering if there's any possibility that Gene A + is fused to Gene B - or even if I've just flat-out misunderstood the output.

    Thanks!

Latest Articles

Collapse

  • SEQadmin2
    Multiomic Liquid Biopsy: What DNA/RNA Panels Reveal That DNA Alone Can’t
    by SEQadmin2



    Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?

    Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating
    ...
    10-14-2026, 09:55 AM
  • SEQadmin2
    New Genomics Technologies Take Aim at Long-Standing Limits
    by SEQadmin2


    Researchers using sequencing and genomics tools often have to make trade-offs. They can choose between speed or scale, short reads or long-range information, or targeted panels or a view of the whole transcriptome. New technologies that have been released this year are built to address those tough choices.

    We asked six companies the same four questions to learn about their latest products. The new technologies bring a lot to the table, including rethinking sequencing
    ...
    09-28-2026, 10:25 AM

ad_right_rmr

Collapse

News

Collapse

Topics Statistics Last Post
Started by SEQadmin2, 10-22-2026, 11:13 AM
0 responses
23 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 10-22-2026, 10:48 AM
0 responses
20 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 10-15-2026, 10:52 AM
0 responses
36 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 10-14-2026, 05:39 AM
0 responses
42 views
0 reactions
Last Post SEQadmin2  
Working...